腎瘻デバイス市場規模、シェア、成長分析：製品別、エンドユーザー別、地域別 - 産業予測 2025～2032年

腎瘻デバイスの世界市場規模は、2023年に13億米ドルと評価され、2024年の14億1,000万米ドルから2032年には27億3,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは8.6％で成長する見通しです。

腎瘻デバイス市場は、世界人口の12%が罹患している尿路結石症を筆頭とする腎臓疾患の有病率の増加と、2023年に米国で新たに81,800人が罹患すると推計される腎臓がん罹患数の増加予測によって大きな成長を遂げています。このような腎臓病の急増は、特にがんによる尿閉に直面している患者に対する腎瘻デバイスの需要を促進しています。その他の市場力学としては、低侵襲手術（MIS）の動向が挙げられます。これらの技術は、従来の手術に比べて回復時間の短縮や合併症リスクの低減など、大きなメリットをもたらすからです。良好な成長見通しとは裏腹に、代替治療の選択肢や関連リスクなどの課題が市場拡大を阻害する可能性があり、戦略立案にあたってはこれらの要因を慎重に考慮する必要があります。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術の進歩

腎瘻デバイス市場規模：製品別& CAGR（2025-2032）

• 市場概要
• ガイドワイヤー
• 排水チューブ
• 腎瘻カテーテル
• シース拡張器
• その他

腎瘻デバイス市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 救急診療所
• 外来手術センター（ASC）
• その他

腎瘻デバイス市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Boston Scientific Corporation（United States）
• Teleflex Incorporated（United States）
• Becton, Dickinson and Company（United States）
• B. Braun SE（Germany）
• Cook Medical Incorporated（United States）
• Coloplast Group（Denmark）
• Olympus Corporation（Japan）
• Medtronic plc（Ireland）
• AngioDynamics Inc.（United States）
• Envaste Limited（United Kingdom）
• Medi-Globe GmbH（Germany）
• UROMED Kurt Drews KG（Germany）
• ROCAMED（France）
• Amecath（Egypt）
• SURGIMEDIK（India）
• Well Lead Medical Co., Ltd.（China）
• TROGE MEDICAL GmbH（Germany）
• Porges SA（France）
• Allium Medical Solutions Ltd.（Israel）

結論と推奨事項

Global Nephrostomy Device Market size was valued at USD 1.3 billion in 2023 and is poised to grow from USD 1.41 billion in 2024 to USD 2.73 billion by 2032, growing at a CAGR of 8.6% during the forecast period (2025-2032).

The nephrostomy devices market is experiencing significant growth driven by the increasing prevalence of kidney disorders, notably urolithiasis affecting 12% of the global population, and the forecasted rise in kidney cancer cases, with an estimated 81,800 new instances in the U.S. for 2023. This surge in kidney disease incidences fuels demand for nephrostomy devices, especially for patients facing urinary blockages due to cancer. Additionally, the trend towards minimally invasive surgical procedures (MIS) is shaping market dynamics, as these techniques provide substantial benefits over traditional surgery, including shorter recovery times and lower risk of complications. Despite favorable growth prospects, challenges such as alternative treatment options and associated risks may impede market expansion, necessitating careful consideration of these factors in strategic planning.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nephrostomy Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nephrostomy Device Market Segmental Analysis

Global Nephrostomy Device Market is segmented by Product, End User and region. Based on Product, the market is segmented into Guidewires, Drainage Tubes, Nephrostomy Catheters, Sheath Dilators and Others. Based on End User, the market is segmented into Hospital, Emergency Clinics, Ambulatory Surgical Centers (ASCs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nephrostomy Device Market

The global nephrostomy device market is significantly driven by ongoing technological advancements that enhance the performance and safety of these medical devices. Innovations such as superior catheter materials, state-of-the-art imaging techniques for precise placement, and advanced drainage systems have markedly improved the efficacy of nephrostomy procedures. As healthcare providers increasingly prioritize the adoption of cutting-edge, efficient devices to optimize patient outcomes, the demand for these innovative nephrostomy solutions continues to rise. This trend highlights the importance of technological evolution in propelling market growth and meeting the evolving needs of medical professionals and patients alike.

Restraints in the Global Nephrostomy Device Market

The global nephrostomy device market faces significant restraints primarily due to the high costs associated with these devices. The expense goes beyond the price of the nephrostomy devices themselves, as it also encompasses necessary consumables and accessories integral to the procedure. This financial burden can hinder the adoption of these devices in various healthcare environments and regions, particularly in facilities with constrained budgets. Additionally, patients experiencing financial difficulties may find it challenging to afford the treatment, further limiting market growth and accessibility. As a result, the high costs remain a crucial obstacle for widespread utilization of nephrostomy devices.

Market Trends of the Global Nephrostomy Device Market

The Global Nephrostomy Device market is experiencing a notable shift towards disposable nephrostomy devices, driven by their clear advantages over traditional reusable options. The increased emphasis on patient safety in healthcare settings has led to a rising adoption of these single-use devices, as they significantly reduce the risks associated with cross-contamination and infection transmission. Furthermore, the convenience and ease of use offered by disposable devices streamline clinical workflows, minimizing the complexities associated with reprocessing and sterilization. This trend indicates a market evolution, with healthcare facilities prioritizing safety and efficiency, thereby enhancing overall patient care and outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Nephrostomy Device Market Size by Product & CAGR (2025-2032)

• Market Overview
• Guidewires
• Drainage Tubes
• Nephrostomy Catheters
• Sheath Dilators
• Others

Global Nephrostomy Device Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospital
• Emergency Clinics
• Ambulatory Surgical Centers (ASCs)
• Others

Global Nephrostomy Device Market Size & CAGR (2025-2032)

• North America (Product, End User)
  • US
  • Canada
• Europe (Product, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coloplast Group (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Envaste Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medi-Globe GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UROMED Kurt Drews KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ROCAMED (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amecath (Egypt)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SURGIMEDIK (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Well Lead Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TROGE MEDICAL GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Porges SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allium Medical Solutions Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations